ICOTROKINRA

ICOTROKINRA was reported 428 times

ICOTROKINRA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BODY SURFACE AREA 1 0.1429
1 GENITAL DRYNESS 2 0.0800
2 VIRAL LOAD 1 0.0058
3 GENITAL CANDIDIASIS 1 0.0047
4 PITYRIASIS RUBRA PILARIS 1 0.0042
5 FALSE POSITIVE TUBERCULOSIS TEST 1 0.0032
6 CHRONIC HEPATITIS B 1 0.0032
7 MILIA 1 0.0028
8 FUNGAL FOOT INFECTION 1 0.0023
9 CREATININE RENAL CLEARANCE ABNORMAL 1 0.0022
10 TINEA CRURIS 1 0.0020
11 TINEA INFECTION 2 0.0018
12 FINGER AMPUTATION 1 0.0014
13 GUTTATE PSORIASIS 1 0.0012
14 CRANIOFACIAL FRACTURE 1 0.0012
15 BLOOD URINE 1 0.0010
16 METABOLIC SURGERY 1 0.0009
17 PRURITUS GENITAL 2 0.0008
18 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 2 0.0008
19 HYPERAESTHESIA TEETH 1 0.0008
20 MENTAL FATIGUE 1 0.0007
21 ACNE CYSTIC 2 0.0007
22 RECTAL CANCER 2 0.0007
23 GASTROSTOMY 1 0.0006
24 TINEA PEDIS 1 0.0006
25 PRODUCT TAMPERING 1 0.0006
26 ARTERIAL DISORDER 1 0.0005
27 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
28 LATENT TUBERCULOSIS 1 0.0005
29 JAW FRACTURE 1 0.0005
30 FAECES PALE 1 0.0004
31 OXYGEN CONSUMPTION INCREASED 1 0.0004
32 DERMAL CYST 1 0.0004
33 CHEILITIS 2 0.0004
34 SQUAMOUS CELL CARCINOMA 3 0.0003
35 BLADDER PAIN 1 0.0003
36 CARDIAC FLUTTER 2 0.0003
37 HERPES SIMPLEX 2 0.0003
38 PRODUCT STORAGE ISSUE 1 0.0003
39 SKIN PLAQUE 2 0.0002
40 PURULENT DISCHARGE 1 0.0002
41 PRODUCT DISPENSING ISSUE 1 0.0002
42 TEARFULNESS 1 0.0002
43 ONYCHOMYCOSIS 1 0.0002
44 HEAVY MENSTRUAL BLEEDING 2 0.0002
45 SUBCUTANEOUS ABSCESS 1 0.0002
46 RASH VESICULAR 1 0.0002
47 STAPHYLOCOCCAL SEPSIS 1 0.0002
48 MALABSORPTION 1 0.0002
49 PRODUCT RESIDUE PRESENT 1 0.0002
50 DERMATITIS ACNEIFORM 1 0.0002
51 SCOLIOSIS 1 0.0002
52 PSORIASIS 19 0.0001
53 HYPERTRANSAMINASAEMIA 1 0.0001
54 PARAESTHESIA ORAL 2 0.0001
55 TENDON PAIN 1 0.0001
56 BRAIN FOG 2 0.0001
57 PRODUCT USE COMPLAINT 2 0.0001
58 HAEMATOCHEZIA 7 0.0001
59 UTERINE CANCER 1 0.0001
60 FRUSTRATION TOLERANCE DECREASED 1 0.0001
61 CANDIDA INFECTION 2 0.0001
62 SKIN HYPERPIGMENTATION 1 0.0001
63 SKIN SWELLING 1 0.0001
64 URINE OUTPUT DECREASED 1 0.0001
65 IMMUNOSUPPRESSION 1 0.0001
66 LOSS OF LIBIDO 1 0.0001
67 PRODUCT DISTRIBUTION ISSUE 1 0.0001
68 HERPES ZOSTER 6 0.0001
69 ATELECTASIS 1 0.0001
70 VITAMIN D DEFICIENCY 1 0.0001
71 PRODUCT DOSE OMISSION ISSUE 30 0.0001
72 KIDNEY INFECTION 2 0.0001
73 GASTROINTESTINAL DISORDER 9 0.0001
74 EMPHYSEMA 1 0.0001
75 TASTE DISORDER 2 0.0001
76 TENDERNESS 1 0.0001
77 PETECHIAE 1 0.0001
78 EYE PRURITUS 3 0.0001
79 SKIN INFECTION 1 0.0001
80 SCAB 1 0.0001
81 MACULAR DEGENERATION 1 0.0001
82 ACCIDENT 1 0.0001
83 CYST 1 0.0001
84 SECRETION DISCHARGE 1 0.0001
85 BEDRIDDEN 1 0.0001
86 TOOTH INFECTION 1 0.0001
87 FREQUENT BOWEL MOVEMENTS 2 0.0001
88 PSORIATIC ARTHROPATHY 3 0.0001
89 HEADACHE 46 0.0001
90 POLLAKIURIA 3 0.0001
91 APHONIA 1 0.0001
92 ABDOMINAL DISCOMFORT 12 0.0001
93 SEASONAL ALLERGY 1 0.0001
94 ABSCESS 1 0.0001
95 SENSORY DISTURBANCE 1 0.0001
96 LIP SWELLING 2 0.0001
97 FUNGAL INFECTION 2 0.0001
98 LYMPHADENOPATHY 2 0.0001
99 ADVERSE DRUG REACTION 5 0.0001
100 RASH PRURITIC 3 0.0001
101 OSTEOMYELITIS 1 0.0001
102 RASH 24 0.0001
103 ADVERSE EVENT 5 0.0001
104 PHOTOPHOBIA 1 0.0001
105 HAEMORRHOIDS 1 0.0001
106 NAUSEA 38 0.0000
107 RETCHING 1 0.0000
108 JOINT INJURY 1 0.0000
109 IMPAIRED WORK ABILITY 1 0.0000
110 IRRITABLE BOWEL SYNDROME 1 0.0000
111 COUGH 13 0.0000
112 SWELLING FACE 3 0.0000
113 MENTAL DISORDER 2 0.0000
114 PRODUCT DISPENSING ERROR 1 0.0000
115 TOOTH DISORDER 1 0.0000
116 RASH PAPULAR 1 0.0000
117 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
118 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
119 PALPITATIONS 5 0.0000
120 LOCALISED INFECTION 1 0.0000
121 MYALGIA 7 0.0000
122 ACNE 3 0.0000
123 DIPLOPIA 1 0.0000
124 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
125 MOOD ALTERED 1 0.0000
126 TREATMENT NONCOMPLIANCE 2 0.0000
127 SKIN LESION 1 0.0000
128 MENTAL STATUS CHANGES 1 0.0000
129 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
130 HAEMOPTYSIS 1 0.0000
131 URTICARIA 6 0.0000
132 WOUND 1 0.0000
133 PAIN IN JAW 1 0.0000
134 FATIGUE 27 0.0000
135 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
136 WHEEZING 2 0.0000
137 VERTIGO 2 0.0000
138 DISCOMFORT 2 0.0000
139 OROPHARYNGEAL PAIN 3 0.0000
140 SWELLING 3 0.0000
141 SWOLLEN TONGUE 1 0.0000
142 PRURITUS 12 0.0000
143 STAPHYLOCOCCAL INFECTION 1 0.0000
144 VIRAL INFECTION 1 0.0000
145 SKIN DISORDER 1 0.0000
146 HEPATIC ENZYME INCREASED 2 0.0000
147 ABDOMINAL PAIN UPPER 6 0.0000
148 NIGHTMARE 1 0.0000
149 RASH MACULAR 1 0.0000
150 ACCIDENTAL OVERDOSE 1 0.0000
151 DYSURIA 1 0.0000
152 DYSGEUSIA 2 0.0000
153 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
154 PAIN 15 0.0000
155 RENAL IMPAIRMENT 2 0.0000
156 HYPERHIDROSIS 3 0.0000
157 MUSCULOSKELETAL STIFFNESS 2 0.0000
158 ANGIOEDEMA 1 0.0000
159 LIVER DISORDER 1 0.0000
160 COLITIS ULCERATIVE 1 0.0000
161 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
162 MUSCLE SPASMS 4 0.0000
163 DIARRHOEA 14 0.0000
164 ABDOMINAL PAIN 5 0.0000
165 OCULAR HYPERAEMIA 1 0.0000
166 MIGRAINE 2 0.0000
167 PRODUCTIVE COUGH 1 0.0000
168 BLOOD GLUCOSE DECREASED 1 0.0000
169 DRY EYE 1 0.0000
170 SOMNOLENCE 4 0.0000
171 FLUSHING 2 0.0000
172 FLUID RETENTION 1 0.0000
173 CHEST DISCOMFORT 2 0.0000
174 THERAPY CESSATION 1 0.0000
175 ARTHRALGIA 8 0.0000
176 ABDOMINAL DISTENSION 2 0.0000
177 DISTURBANCE IN ATTENTION 1 0.0000
178 CONSTIPATION 4 0.0000
179 ANAPHYLACTIC REACTION 1 0.0000
180 ARTHROPATHY 1 0.0000
181 MEDICATION ERROR 1 0.0000
182 NECK PAIN 1 0.0000
183 BLISTER 1 0.0000
184 URINARY TRACT INFECTION 3 0.0000
185 DRUG INEFFECTIVE 23 0.0000
186 SEIZURE 2 0.0000
187 OFF LABEL USE 15 0.0000
188 DYSPHONIA 1 0.0000
189 CHILLS 2 0.0000
190 NASAL CONGESTION 1 0.0000
191 IRRITABILITY 1 0.0000
192 THERAPEUTIC RESPONSE DECREASED 1 0.0000
193 CONDITION AGGRAVATED 5 0.0000
194 OEDEMA PERIPHERAL 2 0.0000
195 RHINORRHOEA 1 0.0000
196 AMNESIA 1 0.0000
197 NEOPLASM MALIGNANT 1 0.0000
198 VOMITING 7 0.0000
199 VISION BLURRED 2 0.0000
200 INJECTION SITE REACTION 1 0.0000
201 DIZZINESS 7 0.0000
202 THERAPY INTERRUPTED 1 0.0000
203 SKIN BURNING SENSATION 1 0.0000
204 BRONCHITIS 1 0.0000
205 HOT FLUSH 1 0.0000
206 UNEVALUABLE EVENT 1 0.0000
207 DEPRESSION 3 0.0000
208 BLOOD PRESSURE INCREASED 2 0.0000
209 HOSPITALISATION 2 0.0000
210 PERIPHERAL SWELLING 2 0.0000
211 BACK PAIN 3 0.0000
212 THROMBOSIS 1 0.0000
213 INFLUENZA LIKE ILLNESS 1 0.0000
214 PYREXIA 4 0.0000
215 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
216 INSOMNIA 3 0.0000
217 TACHYCARDIA 1 0.0000
218 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
219 SUICIDAL IDEATION 1 0.0000
220 CHEST PAIN 2 0.0000
221 DYSPHAGIA 1 0.0000
222 CONTUSION 1 0.0000
223 ALOPECIA 2 0.0000
224 DYSPEPSIA 1 0.0000
225 SINUSITIS 1 0.0000
226 INFLUENZA 1 0.0000
227 SEPSIS 1 0.0000
228 WEIGHT INCREASED 2 0.0000
229 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
230 FEELING ABNORMAL 2 0.0000
231 PRODUCT QUALITY ISSUE 1 0.0000
232 MEMORY IMPAIRMENT 1 0.0000
233 WEIGHT DECREASED 2 0.0000
234 MALAISE 3 0.0000
235 HYPOAESTHESIA 1 0.0000
236 ACUTE KIDNEY INJURY 1 0.0000
237 PARAESTHESIA 1 0.0000
238 CONFUSIONAL STATE 1 0.0000
239 MYOCARDIAL INFARCTION 1 0.0000
240 COVID-19 1 0.0000
241 NASOPHARYNGITIS 1 0.0000
242 HYPERSENSITIVITY 1 0.0000
243 PRODUCT USE ISSUE 1 0.0000
244 ASTHENIA 2 0.0000
245 DYSPNOEA 3 0.0000
246 ERYTHEMA 1 0.0000
247 HYPERTENSION 1 0.0000
248 PAIN IN EXTREMITY 1 0.0000
249 PNEUMONIA 1 0.0000
250 DEATH 1 0.0000